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Summary
In the past we and others have suggested that positive selection of developing thymocytes may
depend upon interaction between the as receptors on these cells and major histocompatibility
complex (MHC) proteins bound to peptides found uniquely in the selecting tissue, thymus cortical
epithelium. To test this hypothesis, peptides were isolated from MHC class II proteins ofspleen,
thymus cortical plus medullary epithelium, or thymus cortical epithelium alone. The results
showed that the major peptides bound to classII on thymus cortical epithelium were also associated
with spleen class II. Some peptides could onlybe detected in isolates from spleen, probably because
of differences in the distribution or uptake of the donor proteins between spleen and thymus.
Thus, although we found some tissue-specific distribution of self-peptides, our data suggest that
there are no fundamental differences among these tissues in the occupancy of class II MHC by
self-peptides. These results limit hypotheses which depend on a specialized mechanism of peptide
generation and/or MHC classII loading to account for the positive selection ofT cells on thymic
cortical epithelium.
any peripheral T cells bear antigen receptors made up
ofa and (3 chains. These receptors are encoded by sets
of genes which rearrange randomly during T cell develop-
ment, such that any given mature T cell may bear 1 of
ti10'z possible receptors on its surface. Even though the
receptor genes of an animal encode a very large number of
possible combinations, it is known that not all receptors are
expressed on the mature T cell pool of any given animal.
In large part this is because the allowed repertoire of receptors
on mature T cells is restricted by two different phenomena
which occur during T cell development. These are the events
which accompany positive and negative selection of thymo-
cytes (1-3).
Both positive and negative selection involve interaction be-
tween the TCRs on developing thymocytes and MHC plus
peptide complexes expressed by cells in the thymus cortex
(3-6). Both events may also involve accessory molecules, CD4
and/or CD8 on the thymocyte surface (7-10). In spite of their
similarities, however, the two events have entirely opposite
outcomes and a number of hypotheses have been put for-
ward to solve this paradox. For example, one hypothesis sug-
gests that tolerance (or mature T cell response) requires, on
the one hand, a fairly high affinity reaction between the
receptors on a developing thymocyte and MHC plus pep-
tide, but that positive selection, on the other hand, might
occur during a very low affinity reaction between the same
two components. Thus, some thymocytes could be selected
to matureby a reaction between receptor and self-MHC plus
self-peptide which is too low to invoke the forces of toler-
ance. These thymocytes would then escape the thymus to
form the mature, self-MHC-restricted pool ofT cells in their
hosts (11, 12).
Some years ago we and others suggested an alternate hy-
pothesis, that positive selection might occur during reaction
between TCRs on developing thymocytes and MHC mole-
cules bearing a special set of self-peptides, found only in the
thymus cortex (13, 14) . The hypothesis stated that thymo-
cytes at this stage of their development might be resistant
to tolerance induction and that, by the time the thymocytes
had become sensitive to tolerance, they would have moved
out of the thymus compartment where these thymus-specific
peptides were to be found.
Since these hypotheses were put forward many investiga-
tions of positive and negative selection have been reported.
Some findings have supported the "low affinity" theory of
positive selection. For example, several papers have shown
that T cells can become reactive to self if they are provided
with more, or functional CD8, acting, perhaps to promote
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shown that T cells activated to attack cells bearing allogeneic
MHC may also attack cells bearing self-MHC, but not "in-
nocent bystander" cells (18).
In contrast, some evidence has also been collected that favors
versions of the "altered peptide" theory. For example, we have
shown that some T cells can react with the thymus cortical
epithelial cells oftheir own host (19), and Murphy et al. (20)
have shown that a particular self-peptide may be found at
fairly high levels bound to I-A of spleen cells, but at much
lower levels on I-A on thymus epithelium. Moreover, there
are also suggestions that early, TCR+, CD4+, and CD8+
thymocytes, unlike their later counterparts, are resistant to
death induced by engagement of their TCRs (21).
The idea that unique selecting peptides are associated with
thymus cortical epithelialMHC has recently been challenged,
however, by two types ofexperiments. Two publications have
shown that positive selection, of at least class I-restricted T
cells, can be driven by MHC bound to foreign peptides, or
to peptides from spleen (22, 23). Three other papers have
shown that positive selection can be effected by reaction be-
tween the receptors on developing thymocytesand MHC pro-
teins on nonspecialized cells such as fibroblasts or those de-
rived from bone marrow (24-26). Both sets ofresults indicate
that no unique properties are required of the selecting ligand
in the thymus.
The recent description ofmethods for isolating and iden-
tifying peptides bound to MHC class I and class 11 (27-29)
has made it possible to perform a direct test of the "altered
peptide" theory of positive selection. The results of such a
test, described here, show that many peptides are shared be-
tween thymus and spleen class II. Some are even shared be-
tween thymus cortical epithelial cells and spleen classII. Some
peptides could only be found in spleen, probably because the
proteins from which they were derived were at higher con-
centration in spleen than thymus. Overall, the results sug-
gest that the major species of peptides bound to MHC on
thymus cortical epithelial cells are also associated with MHC
on spleen and thymus MHC molecules are neither predomi-
nantly empty nor occupied by a set of major peptides unique
to the tissue.
Materials and Methods
Mice.
￿
6-week-old C3H/HeJ female mice were purchased from
Harlan Sprague Dawley Laboratories (Indianapolis, IN). AY mice
were bred in the Animal Care Facility at National Jewish Center.
Breeding pairs ofthe AY mice were the generous gift ofDrs. Benoist
and Mathis (Institut National de la Sant6 et de la Recherche
M6dicale, Strasbourg, France). These animals are transgenic for an
E,1 , gene with a promoter region carrying a deletion of the Y box.
The transgene is expressed only in thymus cortical epithelial cells
and at low levels in B cells and macrophages (30). Consequently,
in mice carrying class II genes of the s haplotype, the haplotype
t Abbreviations used in thispaper: HEL, hen egg lysozyme; 0Zm, /32-micro-
globulin; PCC, pigeon cytochrome c.
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expressed in these mice, expression of the I-E protein is restricted
to these tissues.
I-E'-expressing mice lacking a functional /32-microglobulin
(a2m [31])1 gene were the F2 progeny of a cross between 02m - ,
H-2b mice and B10.BR mice. Experimental mice were selected for
lack of class I and lack of I-A" expression.
Preparation ofPeptidesfrom Class H.
￿
Spleens and thymuses were
isolated from 100-375 mice for each class II preparation. These
yielded between 101° and 4 x 101° cells. Tissue that could not be
dispersed was included in the preparations of cells from thymus,
in that the goal of theexperiment was to isolate class II from thymus
epithelial cells, which might not separate well into single cell sus-
pensions. In each experiment 108 cells of each type were surface
labeled with 1251, to provide a tracelabel, and then added back to
the bulk preparations. Cells were lysed with a buffer containing
2% NP-40, 50 mM iodoacetamide, and 100 /AM PMSF. The lysate
was cleared by spinning at 100,000 g for 2 h. Each lysate was then
divided into thirds and passed sequentially over columns bearing
117/27 (anti-I-Ak), 14-4-4 (anti-I-Ek), or MKS4 (anti-I-A'). The
MKS4 column served as a nonspecific control for preparations from
the I-Ak, I-El-bearing C3H mice. The 17/227 column served a
similar purpose for the I-A', I-E'-bearing AY cells. Each third of
the preparations was passed over thesecolumns in a different order
to ensure that each column was equally exposed to material that
might bind nonspecifically. The columns were then washed and
eluted as described by Buus et al. (32). Elution was followed by
monitoring 1251 counts. The eluates were immediately neutralized
with 2 M Tris, pH 8.0, concentrated on prewashed microconcen-
trators (Centricon 30, Centrico, Inc., Northvale, NJ) and washed
with 10 mM Tris, pH 6.5.
Peptides were eluted on the Centricon 30 microconcentrators
with 2.5 M acetic acid as previously described (28, 32), and were
then isolated by passage through prewashed microconcentrators
(Centricon 10). The eluates were lyophilized and stored at -70°C.
SDS-PAGEAnalysis ofClass IIProteins.
￿
After the peptides had
been eluted from the class II proteins, the quantity of these pro-
teinswas estimated by solubilizing the preparations in buffer con-
taining 0.2 M Tris pH 6.8, 30% glycerol, and 4% SDS (sample
buffer [33]). Samples of the solubilized protein were boiled for 5
min and run on SDS-PAGE in parallel with titrations of known
amounts of standard proteins. The gels were silver stained and the
amounts of class II protein estimated by comparison ofthe intensi-
ties of their bands with those of the protein standards.
In experiments not shown, the percentage of relatively unstable
class II proteins in each preparation was estimated after solubiliza-
tion of the proteins with 3 min incubation on ice in sample buffer
containing 1% SDS. The percentage of associated a(3 chains in
this preparation was then compared with that in apreparation treated
conventionally before electrophoresis (34, 35).
HPLCAnalysis ofClass II-derived Peptides.
￿
Peptides were sepa-
rated by HPLC reverse-phase chromatography using a 2.1 x 15-
cm column (VYDAC C18, The Sep/a/ra/teins Group, Hesperia,
CA) washed with 5 min of isocratic 0.1% TFA/water followed
by a 0-60% linear gradient of 0.1% TFA/water versus 0.083%
TFA/CH3CN over a period of 60 min. Peptides were detected by
absorbance at 214 nm.
Peptide Sequences.
￿
Fractions isolated by HPLC were sequenced
by gas phase Edman degradation on a model 470A/120A protein
microsequencer (Applied Biosystems, Inc., Foster City, CA). Data
analysis was performed using Dynamax chromatography software
(Rainin Instrument Co., Woburn, MA). The molar yield ofeach
peptide was calculated from the concentration ofone of the amino
acids in the peptide corrected for losses estimated from yields ob-tained when a known amount of a standard peptidewas sequenced.
The molar amounts of the class II proteins from which the pep-
tides were derived were estimated by comparison with standards
on silver-stained gels . Peptide and class II molar yields were used
to calculate the percentage of each class II protein occupied by a
given peptide. Genbank was searched to identify the probable pro-
tein sources of the peptides .
Peptide Synthesis.
￿
Synthetic peptides built to match some ofthe
sequences isolated from class II were purchased from Macromolecular
Resources (Fort Collins, CO) or prepared and purified in the Mo-
lecular Resource Center of the National Jewish Center. In some
cases the NH Z-terminal amino acid of a particular peptide isolated
from spleen or thymus was known, but the COOH-terminal end
was unknown, because the sequence of the peptide fell below de-
tectable levels before a well-defined COOH terminal could be
identified. In these cases, synthetic peptides were built to match
the natural peptide, starting at the known NHZ terminal and con-
tinuing for the next 12-16 amino acids.
T Cell Stimulation Assays.
￿
The ability of the peptides identified
in these experiments to bind to class II was assessed by their ability
to block binding of known peptide ligands of the class II in ques-
tion . This was done in T cell hybridoma stimulation assays as pre-
viously described . Antigen-presenting cells, CH12 .1 or LS102.9,
bearing class II I-Ak, I-E k, or I-Ad.', I-Ed .', respectively (36) were
fixed by 30 seconds incubation in 0.1% gluteraldehyde and then
thoroughly washed . 101 of each of these cells were added to mi-
crotiter wells in 50 Al ofbalanced salt solution and various concen-
trations of inhibitor peptide and the mixture incubated at 37°C
for 1 h. 10 1 T hybridoma cells and stimulatory peptides were then
added to each well in 200 p,l ofculture medium . The mixture was
incubated for 24 h at 37°C . The response of the T cell hybridomas
was assessed by measurement of the amount of11,2 that they secreted
(37) .
T cell hybridomas used were as follows : kLy-U, specific for hen
egg lysozyme (46-61) (HEL [46-61])/I-Ak (38) ; h4Ly-50.5, specific
for HEL (46-61)/I-Ak (38) ; 5KC-73.8 (39) and 2B4.6 (40) specific
for pigeon cytochrome c (88-104) (PCC [88-104])/I-Ek ; t3C-32.9
specific for PCC (88-104)/I-E' (unpublished) ; DO-11 .10/S4.4
specific for chicken ovalbumin (323-339 [OVA (323-339])/I-Ad
(41) . Stimulatory peptides were as described for each hybridoma .
In Vivo Responses to Peptide.
￿
B10.BR or H-2k animals lacking
a functional 132m gene (31) were immunized with 20 Rg of 02m
(31-43) in CFA in the base of the tail. 7-9 d later draining lymph
node cells were harvested and cultured for 4 d in Click's medium
containing the same peptide at 100,ug/ml. Dividing cells were then
expanded for 3 d in 11,2 before fusion with a variant ofBW 5147
lacking functional TCR a and (3 chains. Hybrids were selected
as previously described . T cell hybridomas were screened for re-
sponse to the I-Ek-bearing, 02m-expressing B cell lymphoma,
CH12.1, in the presence or absence of additional 0ZM peptide.
Results
We wished to compare the spectrum of peptides bound
toMHC proteins on the tissue responsible for positive selec-
tion, thymus epithelium, and on peripheral tissues in the same
animal . We chose to work with MHC class II proteins, for
which the predominant source in thymus is the thymus epi-
thelium . Peptides from class I proteins could not be used be-
cause class I is expressed in mouse thymus not only on epi-
thelial cells but also on thymocytes. Therefore epithelial-derived
class I could not be examined without extensive prior tissue
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purification . The low yields resulting from such purification
would have made peptide analysis of the type reported here
impossible .
Peptides Bound to Class II on Spleen and Thymus Epithelial
Cells. Peptides were isolated from the class II proteins, I-Ak
and I-Ek, prepared from spleen or thymus of C3H/HeJ
animals. In the normal animals used in these experiments most
of the class II in spleen is borne on resting B cells . As noted
above, most of the class II in thymus is expressed on thymus
cortical or medullary epithelium (42) . The idea that class II
is derived from different cell types in the two tissues is sup-
ported by the finding that thea chains of I-A or I-E purified
from thymus all had somewhat faster mobilities on SDS-PAGE
than those purified from spleen and, in fact, gave two bands
on SDS-PAGE analysis rather than the one found in spleen,
as illustrated in Fig . 1 . These differences are due to the fact
that class II a chains are glycosylated differently in spleen
and thymus, since, after N-glycanase treatment, class II pro-
teins from spleen and thymus ran identically (data not shown) .
Peptides were eluted from the I-A or I-E preparations and
separated by HPLC . The absorbances at 214nm of theHPLC
runs are shown in Fig . 2 . Some of the largest peaks were
found in all runs, including those of control preparations.
These peaks contained no peptides as determined by Edman
degradation (not shown) and were therefore probably caused
by solvents or chemicals extracted from the Centricon micro-
concentrators . Other peaks werecommon to I-A isolated from
either spleen or thymus, but were not found in the control
runs, nor in the peptide preparations isolated from I-E . Con-
versely, many of the I-E peaks were shared between spleen
and thymus but were not found in the I-A preparations. These
peaks, which did turn out to contain peptides, indicate that
some of the peptides bound to I-A or I-E in spleen or thymus
probably are common to the same class II molecule found
in different sites. These peaks also suggest that I-A and I-E
do not bind the same spectrum ofpeptides, not surprisingly.
A few peptide peaks were found in spleen but not thymus.
These may indicate different abilities of thymus and spleen
to capture or produce MHC-bound self-peptides .
Some of the peaks identified in these HPLC runs were se-
quenced and their yields estimated by comparison ofthe molar
yields of the peptides with the known concentration (esti-
mated from silver stained gels) of the donor class II protein .
Figure 1 .
￿
SDS-PAGE analysis
ofclass II isolated from spleen and
thymus . I-Ak and I-Ek were iso-
lated from the thymuses and
spleens of 100 C3H/HeJ animals
as described in Materials and
Methods. 1/100th ofeach prepa-
ration was run in SDS on 12%
PAGE and silver stained . Prepara-
tion sources were as follows : lane
1, I-Ek, spleen ; lane 2, I-Ek,
thymus, lane 3, I-Ak, spleen ; lane
4, I-Ak, thymus. The molecular
masses of markers in kilodaltons
are noted on the figure .E C
a
N
0 N a
Q
Fraction
1
2
3
4
4
5
6
7
8
9
10
11
10 20
Peptide
30 40 50
Retention Time (min)
Table 1 .
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Peptides Bound to I-Ak in C3H/Hej Mice
xQLGA_QNEMLxPV
a vvKKGTD_FQLNQLE
k kGTD_FQLNQLEGKKG
e YVRFDSF_VGEYRAVT
xPL_ALQFAELPVNKG
xP_IDDGGIEA
e eN_LRFDSDVGEFRAV
y EDENL_YEGLNLDDcSMYE
e yiLYNKGIMGEdSYPY
r sYLD_AwVcEQLAT
n serHFV_HQFQPFcyF
h QFQPFcYFTNT
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The results of these analyses, for I-Ak- and I-Ek-derived pep-
tides, respectively, are shown in Tables 1 and 2. Since se-
quencing starts at the NH2-terminal amino acid, the NH2-
terminal end ofeach peptide could be unequivocally identified.
Because only very low amounts of the peptides were isolated,
however, often we could not be certain whether the loss of
readable sequence corresponded to the end of a peptide or
not. Even so, most sequences contained 14 or 15 amino acids
and were therefore similar in length to peptides found by
others bound to class II isolated from cultured cells (28, 29).
Genbank was searched for the likely sources of the pep-
tides. Of the 17 sequences, 14 came from known proteins.
In all cases the peptide sequences matched those of the mouse
Figure 2.
￿
HPLC separations ofpeptides isolated from spleen or thymus
I-A or I-E. Peptides were isolated from spleen and thymus preparations
of I-Ak and I-Ek or material isolated on a control column and fraction-
ated by reverse-phase HPLC as described in Materials and Methods. Shown
are the absorbances at 214 nm oftypical peptide HPLC separations. Splenic
peaks that gave informative sequences are numbered from 1 to 11 for I-Ak
and from 101 to 103 for I-Ek. Peaks eluting at the following minutes gave
no sequence: I-Ak spleen, 17.8, 34.4, 36.4, 37.4, 38.7, 42.5, 46.4, 51.7,
53.2, 55.3; I-Ak thymus, 18.7, 31.5, 33.6, 34.3, 35.9, 50.5; I-Ek spleen,
18.4, 44.5; I-Ek thymus, 48.3. (A) I-Ak spleen; (B) I-Ak thymus; (C) I-Ek
spleen; (D) I-Ek thymus; (E) control thymus.
Peptides were separated and sequenced as described in Materials and Methods. The molar yield of each peptide was calculated from the concentration
of one of the amino acids in the peptide (underlined) corrected for losses estimated from yields when a known amount of standard peptide was
sequenced. The molar amount of donor I-Ak was estimated by comparison with standards on silver-stained gels. Sequences are shown with amino
acids identified by sequencing in capital letters, and those derived from the known sequence of the probable donor protein in lower case. Also shown
in lower case, derived from the probable protein donor, is the amino acid immediately preceding the NH2-terminal amino acid of the identified
peptide. Unidentifiable amino acids in peptides of unknown origin are shown as "x." Fractions indicated as "nd" were not sequenced in the thymus
preparation. We were not sure at which point peptides designated with an NH2-terminal amino acid number only ended. Peptides for which we
were confident of the COOH-terminal amino acid are designated with both an NH2 and COOH-terminal amino acid number.
Possible donor
Percent
Spleen
of MHC occupied in
Thymus
Unknown 0.6 <0.1
Transferrin 100- 2.5 0.3
Transferrin 103- 2.5 0.2
A~ 37-51 9.3 1.1
Unknown 0.5 0.2
Unknown 0.4 <0.1
E'§ 33- 1.6 nd
MBI 177- 9.2 <0.1
Cathepsin H 77- 3.5 0.2
Fce Receptor 11 298- 1.0 <0.1
A~ 3- 0.5 <0.1
A~ 10- 4.3 <0.1Table 2.
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protein identified as the likely donor except for the two pep-
tides thought to be derived from transferrin. The sequence
ofthe mouse transferrin gene has not been published. How-
ever the peptides we found are very similar to sequences in
human transferrin (VVKKDSGFQMNQLRGKK) and pig
transferrin (VVKKGSNFQWNQLQGKR). The peptide
identified as from cathepsin H is identical in sequence to a
peptide from rat cathepsin H. The homologous mouse pro-
tein has not been sequenced.
Of the 10 known donor proteins, 9 are found in the cel-
lular compartments thought to be the sources for class
II-bound peptides; i.e., they are plasma membrane or exoge-
nous proteins. The cellular site of the 10th protein donor,
cognate hsp70, is less certain. It has recently been recognized,
however, that a cognate form ofhsp70 is involved in the trans-
port of proteins into lysosomes, in which case the hsp70 pep-
tide we found bound to I-Ek may be lysosomal in origin
(43).
Some of the class II-bound peptides, for example, trans-
ferrin 100- and transferrin 103-, were overlapping. This
phenomenon has been observedbefore (28, 29) and probably
reflects differential processing of peptides which are bound
by the same core sequence to class II. The fact that class
II-bound peptides can extend beyond the MHC proteins to
varying degrees probably accounts for the fact that it is difficult
to perceive a motif in the sequences of the peptides we found
bound to I-Ak (Table 1). Presumably the sequences of these
peptides does not necessarily reflect the register of the pep-
tides in the class II cleft.
In spite of the differences in register, a motif could be de-
tected for the peptides bound to I-Ek (Table 2). This motif,
which has been noticed in the past by others (44, 45), is il-
lustrated in Table 3. Results presented here and elsewhere
show that I-Ek binding requires a hydrophobic aliphatic res-
idue near the NH2 terminus of the peptide. An amino acid
which can function as a hydrogen bond donor/acceptor is
often found adjacent to this position. Glutamine or asparagine
are usually found five residues COOH terminal to the hy-
drophobic amino acid and a lysine residue is usually found
four or five residues further down the peptide.
5 of the 16 peptides bound to class Ilk contained a pro-
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Peptides were analyzed and are presented as described in Table 1. Abbreviations: C cyt inh, complement cytolysis inhibitor; HSP70, heat shockprotein 70.
line at position 2. This finding suggests that a peptidase with
specificity for peptide sequences with this property might
be involved in the production of some class II-bound peptides.
In these studies we sequenced virtually every fraction eluted
from the HPLC. Although snippets of sequence were ob-
tained at other positions, the peptides described here repre-
sent by far the most abundant found bound to I-Ak and
I-Ek. Since the found peptides account for -35% of I-Ak
and 15% of I-Ek this suggests that the peptides bound to
the remaining 65% and 85% of I-Ak and I-Ek, respectively,
must be at much lower abundance than the ones we could
sequence, i.e., they each must occupy <0.1% of the grooves
of the relevant class II protein. This indicates that each class
II protein in vivo is probably occupied by >100 peptides, and
perhaps by as many as the 2,000, as has been suggested by
some other groups (29). Whether the low abundance pep-
tides are at high enough concentration to affect the reper-
toire of T cells in the animal remains to be established.
Table 3.
￿
Motffor Peptides Bound to I-E"`
Peptide
i32m 31-47
C cyt inh 41-53
HSP70 234-248
MSA 347-361
PCC 88-104
MCC 88-104
Lambda rep 12-26
HEL 81-96
Sequence
HPPHIE_IQMLK_NGK_KIP
VNKEIQNAVQGVK
DNRM_VNHFI_AEF_KRK
TPTL_VEAAR_NLG_RVG
KAERADL_IAYLKQATA_K
ANERADL_IAYLKQAT_K
LEDARR_LKAIY_EKK_K
SALLSSDITASVNCAK
Peptides from this and other studies were aligned according to the I-Ek
binding motif. Underlined residues are those suggested to bind to I-Ek
byJorgensen et al. (45), whereas those conserved throughoutthe sequences
determined in this study are shown in bold. The ability of the PCC,
moth cytochrome c (MCC), lambda repressor (Lambda rep), and HEL
peptides to bind to I-Ek has been described in references 56 and 57.
Fraction Peptide Possible donor
Percentage of
Occupied
Spleen
MHC
in
Thymus
101 f hPpHIEIQMLKNG 02m 31- 3.5 2.8
101 y vNKEIQNAVQGVK C cyt inh 41- 1.9 3.4
102 f HPPH_IEIQMLKNGKKIP /32m 31-47 5.2 nd
103 f dNRMVNHFIAEFKRK Cognate HSP70 234- 2.0 2.0
103 s tPTLVEAARNLGRVG Serum albumin 347- 1.1 2.6Many ofthe peptides had the same HPLC elution position
and sequence regardless of whether they came from spleen
or thymus class II, suggesting that the pathways for protein
processing are similar in the two tissues. There were some
differences in the peptide profiles from the two tissues, how-
ever. Some of the discrepancies were due to differential donor
protein expression in the two tissues since two of the pep-
tides that were unique to spleen were derived from hemato-
poetic or B cell-specific proteins, Re receptor II (46) and
MB1 (47), a member of the surface immunoglobulin com-
plex. Other differences may have been due to differential up-
take of the donor protein by cells in the two tissues. Trans-
ferrin peptides, for example, were readily apparent in isolates
from spleen class 11, but barely discernable in thymus iso-
lates. Growing cells take up more transferrin than resting cells
do, but since neither the thymus epithelium nor the spleen
cells in the noninfected mice used in these experiments are
rapidly dividing, differential growth rates in the two tissues
probably do not account for the differential transferrin pep-
tide distributions. Perhaps resting thymus epithelialcells take
up even less transferrin than resting B cells do, and this ex-
plains the difference.
Overall, these results showed that splenic B cells and thymus
epithelial cells have the capacity to make many of the same
peptides. There may be some differences in their class II pep-
tide profiles, however, usually because of differential avail-
ability of the donor proteins.
Isolation ofPeptidesfrom Class II on Thymus CorticalEpithe-
lial Cells. In normal mice class 11 is expressed on epithelial
cells in both the thymus cortex and medulla. Staining ex-
periments show that medullary cells probably bear >50%
of the class 11 in thymus because, even though they are fewer
in number, they bear much more class II per cell than do
cortical epithelial cells (42). It is therefore possible that the
analysis described above did not reveal the peptides bound
to the class II proteins actually involved in positive selection,
those on cortical epithelial cells.
We therefore repeated the experimentdescribed above using
thymus and spleen from AY mice. Unusual tissue expression
of the transgenic I-Ea gene in these animals leads to expres-
sion ofI-E on thymus cortical but not on thymus medullary
epithelium (30). I-E is also expressed on bone marrow--derived
cells in these animals, at -30% the level of normal mice.
Therefore nearly all the I-E isolated from the thymuses of
AY mice is derived from thymus cortical epithelium.
The AY I-Ed transgene was backcrossed in to B10.S(7R)
mice. The resulting animals expressed I-E, with a tissue dis-
tribution characteristic of AY I-E, was isolated from the
spleens and thymuses of these animals. A low yield of I-E
was obtained from both tissues, a result which reflects the
low levelexpression of I-E. Like the classII a chains isolated
from normal animals, the a chains ofI-E isolated from thymus
ran more quickly on SDS-PAGE than did the cr chains iso-
lated from spleen (data not shown) . This property is there-
fore a characteristic of class 11 expressed on all epithelial cells
in the thymus.
Peptides were eluted from I-E from both tissues, and ana-
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lyzed as described above. Few peptides were unequivocally
identifiedand the sequences appeared more contaminated with
minor species than those obtained from normal mice. This
was in part due to the fact that,because ofexpected low yields,
many more mice were used in for the AY preparations than
for the normal mouse isolations. Perhaps this led to higher
background contamination with peptides produced in tissues
during protein degradation unrelated to class11 binding. For
example, peptides derived from actin were found at several
positions in several ofthe AY isolations. Binding experiments
similar to those described below showed that these actin pep-
tides had no affinity for I-E5, and therefore they were prob-
ably present as contaminants rather than as genuine class 11
associates.
Table 4 contains the sequences and yields ofpeptides that
we are confident were bound to I-E, and one peptide that
we think is probably a contaminant (see below). Two pep-
tides were isolated from I-E, on both spleen and thymus cor-
tical epithelium in relatively high amounts. Genbank searches
showed that both of these peptides were derived from MHC-
associated proteins, one from Ld and the other from a2m.
The latter peptide was identical in HPLC elution profile and
sequence to the #2m peptide isolated from I-Ek. Pigeon
cytochrome c 88-104 also binds to I-E of both the k and s
haplotypes, so perhaps these class II proteins share some re-
quirements for peptide binding.
Some other sequences were present in low amounts, and
complete sequences could not be derived, nor could donor
proteins be identified. Thesesequences were difficult to identify
because, of course, each fraction of the HPLC peptide separa-
tions contained many peptides, most in very low quantities.
Therefore amino acid sequence analysis of many of the pep-
tide HPLC fractions yielded from one to four amino acid
calls at each position. Nevertheless, for some fractions, par-
ticular amino acids were found at the same position upon
sequencing the same peptide HPLC fraction of several inde-
pendent peptide preparations. Sequences identifiedin this way
are shown in Table 4. Although we cannot be sure that each
sequence represents the product of a single peptide, we are
sure that the amino acids shown and their positions in their
donor peptides are characteristic of peptides eluting in that
position on the HPLC. Several of these sequences could be
found in both spleen and thymus although they were in lower
amounts in the thymus preparations, probably because less
I-E could be purified from this tissue.
One peptide of this type was found only in peptide prepa-
rations from spleen. We do not know whether this was be-
cause the donor protein for this peptide was expressed at higher
levels in spleen than in thymus or simply because ofthe small
amounts of I-E, and therefore I-E-derived peptides, which
could be isolated from thymus.
Occasionally sequences were present in thymus but not
spleen. These included the N142-terminal sequence of his-
tone 2B (Table 4) which was found in two independent prepa-
rations of I-E, from AY thymuses but not from spleen.
However, it is likely that this peptide was simply a contaminant
in the preparations because the peptide does not bind I-E,Table 4.
￿
Peptides Bound to I-E' in AY Mice
Peptides were isolated and fractionated as described in Materials andMethods and in the footnote to Table 1. 0.5-ml fractions were collected from
the HPLC separation and fractions were numbered from the time of injection of the peptide preparation into the HPLC loop. Amino acids shown
were found reproducibly in peptides eluting in the fractions indicated from at least two independent isolates of peptides bound to I-D in the spleens
or thymuses of AY mice. Multiple residues were used to determine the amount of peptide applied to the sequencer. In some cases arange of relative
abundances, found in the different preparations analyzed, is given.
in inhibition experiments (see Fig. 4below), and one might
expect histonefragmentsto be at high concentrationin tissues
containing many dying cells, such as the thymus.
Overall, therewasno indication from the fewpeptides we
were able to identify that the peptides boundto thymus cor-
ticalepithelial class II were substantiallydifferent from those
bound to class II of spleen. Also, there was no indication
that class II on thymus cortical epithelium might be empty.
This conclusion was supported by preliminary experiments
(not shown), which demonstrated that the percentages of
unstable I-Eproteins in spleen and thymus ofAY mice were
similar (34, 35).
Demonstration That thePeptides Foundin TheseAnalyses Bind
to Class H. In order to prove that the peptides we had
identified were indeed derivedfrom theantigen-bindingclefts
of class II, some of the peptides were synthesized and tested
fortheir ability to bind to theclefts oftheappropriate MHC
protein in antigen presentation inhibition assays (47a). As
shown in Fig. 3 nearly all the peptides so tested had activity
in such assays. For example, A~ 3-17 or 37-52 blocked rec-
ognition of I-Ak plus HEL (46-61) by a T cell hybridoma
but hadno effect on recognition ofPCC (88-104) by another
hybrid. The I-Ek-associated 02m (31-45) had the reverse ac-
tivity.
As expected, the 02m peptide also inhibited the response
of a T cell hybridoma specific for PCC (88-104) plus I-Es
(Fig. 4), demonstrating that the 02m peptide could bind to
this allele of I-E. Likewise, the Ld peptide isolated from AY
animals inhibited the same hybrid. The histone 2B fragment
described in Table 4 had no inhibitory activity in these ex-
periments (datanot shown) . Apeptidebuilt to matcha pre-
sumed leader sequence for V137 was used as a negative con-
trol in the experiments shown in Fig. 4.
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Figure 3.
￿
Peptides isolated from f--Ak or I-Ek bind to these proteins.
Peptides were synthesized to match some of the sequences identified in
Table 1. In each case the peptides started at the known NHZ terminal of
the sequenced peptide and continued for the next 15 amino acids. The
peptides were titrated for their ability to interfere with presentation of
stimulatory peptides by fixedCH12.1 cells to Tcell hybridomas (Materials
andMethods). Responding cellsandstimulatory peptides were asfollows:
(A) kLy-4.3 plus 60 wg/ml HEL (46-61); (B) h4Ly-50.5 plus 60 Ag/ml
HEL (46-61); (C) 5KC-73.5 plus 2t~g/ml PCC(88-104); (D) 2B4.6 plus
60 p.g/ml PCC (88-104). Inhibitor peptides were: A0k (3-17) /; A0k
(37-52) "; Fce II receptor (298-310) A; (32m (31-45) p.
Fraction Peptide Possible donor
Percentage of
occupied
Spleen
MHC
in
Thymus
47-48 XXXLK I XXKG Unknown 0.5-1 .3 0.6
58-61 HPPH I E I QMLKNGK 0Zm 31-44 2.4 >1 .7
60-63 EGECVEWLHRYKNGNA Ld 160-175 2.7 >4.9
61-62 XXQ I LXLXGK Unknown 1.4 <0.1
88-90 X I MPFLKLFPG Unknown 0.6 0.1-1.0
99-100 pEPAKxAPApK Histone 2B 1- <0.1 0.2-1.2N
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Figure 4.
￿
Two peptides associated with I-D on thymus cortical epi-
thelium and spleen do bind I-D. The peptides 02m (31-45) and Ld (160-
176) were titrated for their ability to inhibit presentation ofPCC (88-104)
to the PCC (88-104)/I-El-specific T cell hybridoma, t3C-32.9. Controls
included evaluation of the effects ofa nonspecific peptide on the response
of this hybrid, and evaluation of the effects of the two I-ELassociated pep-
tides on the responses ofT cells to peptides bound to I-Ak or I-Ad. Cul-
tures were set up as described in Materials and Methods and the legend
to Fig. 3 and included the following: (A) t3C-32.9 plus fixed LS-102.9
cells plus 40 pg/ml PCC (88-104) plus 02m (31-45) A, V07 leader pep-
tide O; DO-11.10/S4.4 plus fixed LS-102.9 cells plus 20 kg/ml OVA (323-
339) plus 02m (31-45) A; (B) t3C-32.9 plus fixed LS-102.9 cells plus 20
ug/ml PCC (88-104) plus Ld (160-176) N, V07 leader peptide O; kLy-
4.3 plus fixed CH12.1 cells plus 62.5 Wg/ml HEL (46-61) plus Ld (160-
176) 0.
Mice Are Tolerant to Class H-bound Peptides.
￿
Mice have been
produced which do not express i02m. These animals, which
originally bore H-2b, were crossed with B10.BR mice and
F2 animals were selected which were homozygous for the
"knocked out" 02n1 gene and for H-2k. These animals, and
normal B10.BR animals, were immunized with 02m (31-45)
in CFA. T cells were isolated from the mice, expanded with
antigen in vitro, and converted into T cell hybridomas. As
shown in Table 5, 38% of the T cell hybrids obtained from
02m - mice responded to the 02m peptide, and, in fact,
responded to an I-Ek-expressing B cell lymphoma in the ab-
sence ofadded peptide. Presumably the lymphoma expressed
the peptide/I-E combination naturally. By contrast, none of
the hybridomas from B10.BR mice responded to the lym-
phoma cells in the presence or absence of added 02m pep-
tide. Therefore the normal animals were indeed tolerant to
a peptide/class II combination which is expressed on their
own cells.
Discussion
All theories of positive and negative selection have to ex-
plain both the skewing of the selected T cell repertoire to-
ward foreign peptides presented by the selecting MHC allele
and the failure of the mature selected T cells to react with
the selecting MHC molecule complexed with any ofthe self-
peptides found in the periphery. The "affinity hypothesis"
suggests that some mechanism in the thymus allows imma-
ture T cells to register TCR interactions with MHC/self-
peptide complexes at affinities that are below the threshold
Table 5.
￿
Normal 1-E' Expressing Mice are Tolerant
to B2m (31-45)
Mice
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Percent reactive T cell
hybrids (No. tested)
B10.BR
￿
0 (38)
Bl0.BR62m - ￿38 (216)
B10.BR or B10.BR02m- mice were immunized with 02m (31--45) in
CFA. T cells from the draining lymph nodes were later stimulated with
the peptide in vitro, expanded in IL-2 and fused. Hybridomas were as-
sayed for their response to I-Ek plus the /32m peptide .
capable of tolerizing or triggering a more mature T cell. The
"altered peptide hypothesis" proposes that the selecting MHC
ligands in the thymus are unique to that tissue, either be-
cause the MHC molecules in that tissue are not bound to
peptides at all orbecause they are occupied by peptides unique
to the thymus.
Both of these hypotheses have advantages and disadvan-
tages in explaining the existing data. For example, the affinity
hypothesis, on the one hand, obviates the need both for a
specialized MHC bearing cell and for a temporal order for
positive and negative selection, because the outcome of the
signaling is controlled by the quality of the TCR/MHC in-
teraction. On the other hand, the altered peptide hypothesis
does not require a special signaling mechanism mediated by
very low affinity TCR/MHC interactions. It has not yet been
possible to design an experiment to distinguish definitively
between these hypotheses. The difficulties are due both to
our inability to measure the affinity of the selecting TCR/
MHC interaction directly and to our lack of knowledge of
the precise nature ofthe selecting MHC ligand. Consequently,
most recent experiments, such as those presented here, serve
to place limitations on these hypotheses rather than elimi-
nate one altogether.
In order to examine the altered peptide hypothesis we com-
pared the peptides associated with class II derived from spleen
and thymic cortical and medullary epithelium. Examination
of peptides bound to I-Es in AY mice showed that class 11
on thymus cortical epithelium certainly has bound peptides.
The six identified peptides accounted for N8% of the pep-
tides binding sites on I-E regardless of whether the MHC
protein was isolated from spleen or thymus. These results
showed that MHC proteins on selecting tissue are not oc-
cupied by a few dominant thymic-specific peptides. The fact
that the percent occupancy by the few peptides we could iden-
tify was the same for spleen and thymus cortical I-E suggests
that most cortical I-E molecules are bound to peptides. We
found no indication that a substantial amount of this mate-
rial is empty. Finally, the peptides identified in spleen and
thymus had the same sequence and eluted at the same posi-
tions on reverse-phase HPLC; thus spleen cells and thymus
cortical epithelial cells are able to process these proteins intothe same fragments. We conclude that (a) thymic cortical
epithelial cells are similar to peripheral class II-bearing cells
in their ability to generate and load peptides into class 11 and
(b) thymic cortical epithelial class II is not occupied by a set
ofdominant peptides different from that found on spleen cells.
These results obviously place limitations on the altered pep-
tide hypothesis, whilenot eliminating it entirely. For example,
one could still make the ad hoc argument that only some
classII on thymic cortical epitheliumis loaded with peptides
similar to those on peripheral class II, but that the rest is
empty or occupied by peptides derived from normal thymus-
specific proteins or even special thymic selecting peptides. In
order to eliminate this possibility altogether, the majority
of the peptides in thymic class II would have to be sequenced,
a task impossible with current technology.
There is other recent evidence that argues against the al-
tered peptide hypothesis. Several groups, including ourselves,
have now shown that positive selection can occur during reac-
tion between receptors on developing thymocytes and bone
marrow-derived cells, or fibroblasts, in the thymus (24-26).
The overall finding of experiments of this type is that non-
specialized cell types can present MHC for positive selection
providing those cells bear the MHC protein in question, and
are present in the thymus cortex. Such a conclusion indicates
that production of MHC proteins bearing a specialized set
of peptides is not a prerequisite for positive selection. Others
have shown that MHC classI proteins bearing synthetic pep-
tides, or pooled peptides isolated from spleen, can partici-
pate in positive selection (22, 23), again suggestingthat spe-
cial peptides are not required for this function.
If nonspecialized cells bearing peptide/MHC complexes
found also in the periphery can drive positive selection, then
the thymocyte itself must determine whether interaction be-
tween a particular TCR/MHC pair will result in positive
or negative selection. The affinity hypothesis attempts to ex-
plain the phenomenon along these lines by proposing that
the thymocyte can detect the affinity of the TCR/MHC in-
teraction (11) . Recent evidence supports this idea. For ex-
ample, several groups have shown that increases in the levels
of accessory molecules such as CD8 can convert events that
normally lead to positive selection into those that cause toler-
ance, i.e., an increase in the avidity with which the thymo-
cyte reacts with target cells converts positive into negative
selection (15, 16).
If positive selection does involve a low affinity reaction be-
tween the thymocyte receptor and MHC, how does the
thymocyte detect this and distinguish it from a high affinity
reaction? If no other molecules are involved, then ther-
modynamics dictate that high and low affinity reactions are
distinguished by two features. First, at any given concentra-
tions of receptor and ligand, fewerreceptors will be engaged
at any one time if the reaction is of low, rather than of high,
affinity. Secondly, regardless of concentration, the half-life
of a given low affinity receptor/ligand complex will be shorter
than that of a high affinity complex. Therefore the thymo-
cyte could detect the affinity of the reaction between its
receptor and peptide/MHC by measuring either the number
ofreceptors engaged at any one time and/or the time of en-
gagement ofany given pair. Ofthese two differences perhaps
the more reliable indicator is the time of engagement, be-
cause the number of receptors engaged at any one time is
concentration dependent, and the concentration of a partic-
ular self-peptide/MHC complex mayvary from tissue to tissue,
as illustrated in this paper.
In support of this idea, the dissection of the signaling path-
way from the TCR has suggested a complex mechanism with
an accumulating signal built up as various intracellular and
surface molecules are pulled into an aggregating TCR/MHC
complex (48). Low affinity TCR/MHC interactions might
dissociatebefore a fully aggregated complex forms resulting
in a partial set of signals. In the developing thymocyte this
may determine positive versus negative selection (49). Similar
ideas have been suggested to account for the differential effects
ofagonist and antagonist peptides on mature T cells (50-54)
and affinity maturation of antibody responses (55).
Finally, several groups have analyzed the peptides bound
to class I and class II proteins on cultured cells and there are
a few reports of the peptides bound to classI MHC in normal
mice (27-29). So far, however, there has been no description
of the peptides bound to classII molecules in animals. More-
over, there has been no published analysis of the differences
in peptides bound to class II on different tissues. The matter
is of some interest, because many autoimmune reactions are
thought to be driven by class II-restricted T cells that recog-
nize tissue-specific peptide class II complexes. The data in
this paper show that this is possible. Analysis ofpeptides de-
rived from class II on spleen cells and thymus epithelialcells
revealed that, although many peptides were shared between
the two sources, some peptides were found in one tissue only.
This was usually due to the fact that the donor proteins for
these peptides are well expressed in one tissue (the spleen)
but not the other (the thymus). Thus class II proteins in
different tissues are bound, to some extent, by different pep-
tides, and tissue specific attack by class II-restricted autoreactive
T cellsbased on this differential peptide distribution is a pos-
sibility.
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